Log in

Five Prime Therapeutics SEC Filings & 10K Form (NASDAQ:FPRX)

$3.92
+0.03 (+0.77 %)
(As of 11/12/2019 03:01 AM ET)
Today's Range
$3.64
Now: $3.92
$3.94
50-Day Range
$3.63
MA: $4.09
$5.23
52-Week Range
$3.22
Now: $3.92
$13.97
Volume319,736 shs
Average Volume371,070 shs
Market Capitalization$144.18 million
P/E RatioN/A
Dividend YieldN/A
Beta2.55

SEC Filings

Five Prime Therapeutics (NASDAQ:FPRX) SEC Filings

DateFilerForm TypeView
11/08/2019
4:17 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
Form SC 13G/A
11/07/2019
6:22 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
4:16 PM
Five Prime Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
5:24 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2019
4:43 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2019
4:30 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2019
3:12 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2019
3:06 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
6:30 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2019
4:40 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:42 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2019
3:42 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
Form SC 13G/A
09/19/2019
3:32 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
12:20 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
12:18 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
12:15 PM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
12:12 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
11:15 PM
Five Prime Therapeutics (Filer)
Form EFFECT
08/22/2019
5:50 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
3:07 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
3:47 PM
Five Prime Therapeutics (Filer)
Form S-3/A
08/07/2019
7:48 PM
Five Prime Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
3:17 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2019
9:17 AM
Five Prime Therapeutics (Filer)
Form CT ORDER
08/02/2019
9:11 AM
Five Prime Therapeutics (Filer)
Form CT ORDER
08/02/2019
9:00 AM
Five Prime Therapeutics (Filer)
Form CT ORDER
07/31/2019
3:10 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
3:08 PM
Five Prime Therapeutics (Subject)
Form SC TO-I/A
07/10/2019
1:58 PM
Five Prime Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
07/01/2019
5:08 AM
Five Prime Therapeutics (Subject)
Form SC TO-I
06/28/2019
3:07 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2019
3:35 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:30 PM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:28 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:25 PM
Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:10 PM
Five Prime Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:08 PM
Five Prime Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2019
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2019
5:37 PM
Five Prime Therapeutics (Issuer)
Nicholson Garry A (Reporting)
Form 3/A
06/12/2019
5:28 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:26 PM
Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:23 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:21 PM
BERGER FRANKLIN M (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:18 PM
Five Prime Therapeutics (Issuer)
Nicholson Garry A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:15 PM
Five Prime Therapeutics (Issuer)
Jensen Peder (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:11 PM
Dhingra Kapil (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:09 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
12:53 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
5:42 PM
Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
5:34 PM
Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2019
5:29 PM
Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
4:11 PM
Five Prime Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/09/2019
3:31 PM
Five Prime Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
12:21 PM
Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
Form 3/A
05/02/2019
12:15 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 3/A
05/02/2019
12:12 PM
Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
Form 3/A
04/29/2019
5:09 AM
Five Prime Therapeutics (Filer)
Form DEF 14A
04/12/2019
5:10 AM
Five Prime Therapeutics (Filer)
Form PRE 14A
04/04/2019
3:43 PM
Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
Form 4/A
04/03/2019
3:41 PM
Five Prime Therapeutics (Filer)
Form CT ORDER
03/19/2019
9:56 AM
Five Prime Therapeutics (Filer)
Form CT ORDER
03/18/2019
3:07 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
5:21 PM
Five Prime Therapeutics (Issuer)
White David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:12 PM
Five Prime Therapeutics (Issuer)
White David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/04/2019
3:06 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2019
5:15 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4/A
02/27/2019
7:07 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
7:01 PM
Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
6:58 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
6:53 PM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
6:49 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
3:04 PM
Five Prime Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G/A
02/13/2019
10:52 AM
Five Prime Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/13/2019
5:50 AM
Five Prime Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
02/12/2019
8:43 AM
Five Prime Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/11/2019
8:29 AM
Five Prime Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/07/2019
4:24 PM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
4:21 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
4:18 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
4:14 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2019
3:08 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2019
5:07 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
5:10 AM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2018
3:10 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2018
6:21 PM
Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
6:10 PM
Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2018
7:32 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
8:05 AM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2018
3:00 PM
Five Prime Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G
10/04/2018
4:09 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
Form SC 13G/A
10/02/2018
5:50 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
5:46 PM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
5:43 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2018
11:12 AM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
11:58 AM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2018
11:29 AM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 11/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel